Anzeige
Meldung des Tages: Die neue Black-Pearl-Analyse bringt Struktur in die nächste Entdeckungsstory

CalciMedica News

Aktie
WKN:  ISIN:  US38942Q2021 US-Symbol:  CALC Branche:  Biotechnologie Land:  USA
0,561 $
-0,0288 $
-4,88%
0,47906 € 16:51:18 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
16,16%
KGV
-3,50
Index-Zuordnung
-

CalciMedica News

03.03.26 - PR Newswire
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates PR Newswire
28.01.26 - PR Newswire
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation PR Newswire
12.11.25 - PR Newswire
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire
12.11.25 - PR Newswire
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension PR Newswire
10.11.25 - PR Newswire
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 PR Newswire
14.10.25 - PR Newswire
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ PR Newswire
02.09.25 - PR Newswire
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire
12.08.25 - PR Newswire
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire
08.07.25 - PR Newswire
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference PR Newswire
25.06.25 - PR Newswire
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure ...
12.06.25 - PR Newswire
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-​CRRT-EBPT and Critical Care Nephrology Meeting PR Newswire
14.05.25 - PR Newswire
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »